Nuvalent

Developer of therapeutic solutions for the treatment of cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups92 employees language nuvalent.com

Registered entities

Innovation

14 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 3,512 times.

YearFilings
20212
20223
20237
202411
202510

Social engagement

Social engagement: 20.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Deerfield, Bain Capital Life Sciences.

Investor typeCountShare
Venture capital542%
Private equity18%
Bank & private debt217%
Other / undisclosed433%

Hiring activity

Hires periodically

8 roles tracked across 3 of the last 12 months

5 Feb 2026 · Associate Director, Chemical Development · Cambridge

1 Feb 2026 · Director, Human Resources Business Partner · Cambridge

29 Dec 2025 · Vice President, Regulatory Affairs · Cambridge

11 Nov 2025 · Manager, Regulatory Advertising & Promotion Submissions · Cambridge

9 Nov 2025 · Director, Scientific Communications · Cambridge

Based on job postings tracked across public sources.

Recent activity

8 Jun 2026
Event
2026 American Society of Clinical Oncology (ASCO) Annual Meeting
21 May 2026
Event
2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Coming soon